ATE107353T1 - Blutplättchenlysat, verfahren zu seiner herstellung sowie ein solches lysat enthaltendes zellkulturmedium. - Google Patents

Blutplättchenlysat, verfahren zu seiner herstellung sowie ein solches lysat enthaltendes zellkulturmedium.

Info

Publication number
ATE107353T1
ATE107353T1 AT89905220T AT89905220T ATE107353T1 AT E107353 T1 ATE107353 T1 AT E107353T1 AT 89905220 T AT89905220 T AT 89905220T AT 89905220 T AT89905220 T AT 89905220T AT E107353 T1 ATE107353 T1 AT E107353T1
Authority
AT
Austria
Prior art keywords
lysate
pct
platelets
cell culture
platelet
Prior art date
Application number
AT89905220T
Other languages
English (en)
Inventor
Olov Holmqvist
Bengt Westermark
Original Assignee
Ellco Food Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellco Food Ab filed Critical Ellco Food Ab
Application granted granted Critical
Publication of ATE107353T1 publication Critical patent/ATE107353T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT89905220T 1988-04-26 1989-04-26 Blutplättchenlysat, verfahren zu seiner herstellung sowie ein solches lysat enthaltendes zellkulturmedium. ATE107353T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8801537A SE8801537D0 (sv) 1988-04-26 1988-04-26 Cellodlingsmedium samt forfarande for dess framstellning

Publications (1)

Publication Number Publication Date
ATE107353T1 true ATE107353T1 (de) 1994-07-15

Family

ID=20372119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89905220T ATE107353T1 (de) 1988-04-26 1989-04-26 Blutplättchenlysat, verfahren zu seiner herstellung sowie ein solches lysat enthaltendes zellkulturmedium.

Country Status (8)

Country Link
US (1) US5198357A (de)
EP (1) EP0413727B1 (de)
JP (1) JPH03505156A (de)
AT (1) ATE107353T1 (de)
AU (1) AU3539289A (de)
DE (1) DE68916244T2 (de)
SE (1) SE8801537D0 (de)
WO (1) WO1989010398A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723443A (en) * 1988-02-02 1998-03-03 Hankyu-Kyoei Bussan Co. Ltd. Lipid metabolism promoting agent and its use
JPH04198129A (ja) * 1990-11-28 1992-07-17 Sumitomo Pharmaceut Co Ltd 活性型ビタミンｄ↓３類含有組成物
ES2184236T3 (es) * 1997-02-06 2003-04-01 Therasense Inc Sensor in vitro de analitos de pequeño volumen.
JP3521382B2 (ja) * 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
DE19821060A1 (de) 1997-09-23 1999-04-15 Bundesrepublik Deutschland Let Ko-stimulierendes Polypeptid von T-Zellen, monoklonale Antikörper sowie die Herstellung und deren Verwendung
JP4463418B2 (ja) * 1997-09-23 2010-05-19 ドイツ連邦共和国 Ｔ細胞共同刺激性ポリペプチド、モノクローナル抗体、ならびにその製法および使用
EP1740617B1 (de) 2004-04-23 2013-10-16 BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Präsidenten Verfahren zur behandlung von erkrankungen, die mit t-zellen im zusammenhang stehen, durch eliminierung von icos-positiven zellen in vivo
US20060039991A1 (en) * 2004-08-20 2006-02-23 Alberto Gorrochategui Barrueta Biological tissue regenerative agent and method for preparing and using same
EP1880206B1 (de) * 2005-05-09 2012-11-14 Affymetrix, Inc. Multiplex-einfang von nukleinsäuren
US8632970B2 (en) 2005-05-09 2014-01-21 Affymetrix, Inc. Multiplex capture of nucleic acids
WO2006124771A2 (en) * 2005-05-12 2006-11-23 Panomics, Inc. Multiplex branched-chain dna assays
US20080038725A1 (en) * 2005-06-20 2008-02-14 Yuling Luo Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
SE0501462L (sv) * 2005-06-23 2006-09-26 Proliff Ab Förfarande för framställning av blodplättslysat
US7927798B2 (en) * 2005-10-05 2011-04-19 Panomics, Inc. Detection of nucleic acids from whole blood
CA2640185A1 (en) * 2006-01-24 2007-08-02 Christopher J. Centeno Mesenchymal stem cell isolation and transplantation method and system to be used in a clinical setting
WO2008034803A1 (en) * 2006-09-18 2008-03-27 Medizinische Universität Graz Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
US9095562B2 (en) 2007-07-05 2015-08-04 Regenerative Sciences, Inc. Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
US20110200642A1 (en) * 2007-12-19 2011-08-18 Regenerative Sciences, Llc Compositions and Methods to Promote Implantation and Engrafment of Stem Cells
US20110052533A1 (en) * 2008-03-14 2011-03-03 Regenerative Sciences, Llc Compositions and Methods for Cartilage Repair
EP2310006A4 (de) 2008-07-03 2012-04-25 Mayo Foundation Krebsbehandlung
EP2334785B2 (de) * 2008-09-16 2019-08-14 Mayo Foundation For Medical Education And Research Zusammensetzungen mit thrombozytengehalt
JP2012510874A (ja) 2008-12-05 2012-05-17 リジェネレイティブ サイエンシーズ， エルエルシー 無血管組織の修復を促進するための方法及び組成物
US20100168022A1 (en) * 2008-12-11 2010-07-01 Centeno Christopher J Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens
US20110054929A1 (en) * 2009-09-01 2011-03-03 Cell Solutions Colorado Llc Stem Cell Marketplace
HUP0900603A2 (en) * 2009-09-25 2012-02-28 Biomarker Kft Cell culture medium
US9113950B2 (en) 2009-11-04 2015-08-25 Regenerative Sciences, Llc Therapeutic delivery device
EP3034625B1 (de) 2010-10-21 2017-10-04 Advanced Cell Diagnostics, Inc. Hochsensitives verfahren für den in-situ-nachweis von nukleinsäuren
ES2792062T3 (es) 2011-05-09 2020-11-06 Mayo Found Medical Education & Res Tratamientos contra el cáncer
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
WO2012158983A2 (en) 2011-05-17 2012-11-22 Qiyong Peter Liu Improved platelet storage using a sialidase inhibitor
ES2811085T7 (es) * 2011-06-27 2021-11-29 Univ Emory Composiciones, usos y preparación de lisados de plaquetas
EP2540819A1 (de) * 2011-06-27 2013-01-02 Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) Verfahren zur Kultivierung von Zellen in einem Medium mit Plättchenlysat
US9133438B2 (en) 2011-06-29 2015-09-15 Biorestorative Therapies, Inc. Brown fat cell compositions and methods
LT2729562T (lt) 2011-07-06 2018-07-25 Cell Therapy Limited Mezodermos ląstelių linijos kamieninės ląstelės
ITRM20110500A1 (it) * 2011-09-23 2013-03-24 Futura Stem Cells Sa Lisato piastrinico, usi di esso e metodo per la sua preparazione
AU2012342218B2 (en) 2011-11-23 2017-03-02 Cell Therapy Limited Platelet lysate gel
ES2899643T3 (es) 2012-10-01 2022-03-14 Mayo Found Medical Education & Res Tratamientos para el cáncer
EP2903430A1 (de) 2012-10-05 2015-08-12 Velico Medical, Inc. Plättchenadditivlösung mit beta-galactosidase-inhibitor
EP2733200A1 (de) 2012-11-15 2014-05-21 Biorigen International SA Zellkulturzusätze
KR20150113978A (ko) * 2013-01-28 2015-10-08 리제너러티브 사이언시즈, 엘엘씨 혈소판 용해 및 활성화를 위한 디바이스 및 방법
WO2014120886A1 (en) 2013-01-30 2014-08-07 Velico Medical, Inc. Platelet additive solution having a self-assembling hydrogel-forming peptide
EP3795678B1 (de) 2013-04-19 2023-07-12 Biorestorative Therapies, Inc. Stammzellen aus menschlichem braunen fettgewebe und verwendungen
JP6649257B2 (ja) * 2013-08-27 2020-02-19 クック・ジェネラル・バイオテクノロジー・エルエルシー 濃厚血小板から誘導可能な生理活性組成物並びにその調製方法及び使用方法
EP3143130B1 (de) 2014-05-16 2024-03-06 Mayo Foundation for Medical Education and Research Zellkulturmedienzusammensetzungen für primärzellen
GB201410504D0 (en) 2014-06-12 2014-07-30 Cell Therapy Ltd Immuno-modulaltory progenitor (IMP) cell
AU2015274408A1 (en) 2014-06-13 2017-01-12 Mayo Foundation For Medical Education And Research Treating lymphomas
US10213513B2 (en) 2014-06-16 2019-02-26 Mayo Foundation For Medical Education And Research Treating myelomas
US9446148B2 (en) 2014-10-06 2016-09-20 Mayo Foundation For Medical Education And Research Carrier-antibody compositions and methods of making and using the same
GB201513996D0 (en) 2015-08-07 2015-09-23 Cell Therapy Ltd Immuno-oncology mesodermal progenitor (IOMP) cell
TW201707725A (zh) 2015-08-18 2017-03-01 美國馬友醫藥教育研究基金會 載體－抗體組合物及其製造及使用方法
KR20170037379A (ko) * 2015-09-25 2017-04-04 (주)프로스테믹스 세포의 증식 촉진용 조성물 및 이를 포함하는 세포 배양용 배지
TW201713360A (en) 2015-10-06 2017-04-16 Mayo Foundation Methods of treating cancer using compositions of antibodies and carrier proteins
EP3362462B1 (de) 2015-10-12 2021-07-21 Advanced Cell Diagnostics, Inc. In-situ-detektion von nukleotidvarianten bei proben mit hohem rauschen sowie zugehörige zusammensetzungen und verfahren
GB201518263D0 (en) 2015-10-15 2015-12-02 Oxford Bioelectronics Ltd Method
US11571469B2 (en) 2016-01-07 2023-02-07 Mayo Foundation For Medical Education And Research Methods of treating cancer with interferon wherein the cancer cells are HLA negative or have reduced HLA expression
US11351254B2 (en) 2016-02-12 2022-06-07 Mayo Foundation For Medical Education And Research Hematologic cancer treatments
CA3018341A1 (en) 2016-03-21 2017-09-28 Mayo Foundation For Medical Education And Research Methods for reducing toxicity of a chemotherapeutic drug
WO2017165439A1 (en) 2016-03-21 2017-09-28 Mayo Foundation For Medical Education And Research Methods for improving the therapeutic index for a chemotherapeutic drug
US10618969B2 (en) 2016-04-06 2020-04-14 Mayo Foundation For Medical Education And Research Carrier-binding agent compositions and methods of making and using the same
US20200325442A1 (en) 2016-06-02 2020-10-15 Pl Bioscience Gmbh Method for producing a platelet-lysate-containing gel
EP3506950A1 (de) 2016-09-01 2019-07-10 Mayo Foundation for Medical Education and Research Gegen t-zell-karzinome gerichtete verfahren und zusammensetzungen
CA3035378A1 (en) 2016-09-01 2018-03-08 Mayo Foundation For Medical Education And Research Carrier-pd-l1 binding agent compositions for treating cancers
EP3509635A1 (de) 2016-09-06 2019-07-17 Vavotar Life Sciences LLC Verfahren zur behandlung von dreifach negativem brustkrebs unter verwendung von zusammensetzungen aus antikörpern und trägerproteinen
AU2017324335A1 (en) 2016-09-06 2019-03-28 Mayo Foundation For Medical Education And Research Methods of treating PD-L1 expressing cancer
EP3509643A1 (de) 2016-09-06 2019-07-17 Mayo Foundation for Medical Education and Research Paclitaxel-albumin-bindende wirkstoffzusammensetzungen und verfahren zur verwendung und herstellung davon
CN109468262A (zh) * 2018-10-30 2019-03-15 中国科学院苏州生物医学工程技术研究所 家畜血细胞制备动物细胞培养液的方法及其制得的动物细胞培养液的应用
EP3911733B1 (de) 2019-01-15 2024-08-21 Cell Therapy Limited Mesodermale killerzelle (mk)
GB201900554D0 (en) 2019-01-15 2019-03-06 Cell Therapy Ltd Mesodermal killer (mk) cell
CN110484497A (zh) * 2019-09-05 2019-11-22 中国人民解放军南部战区总医院 一种血小板裂解液及其制备方法和应用
US11951134B2 (en) 2019-09-30 2024-04-09 North Carolina State University Cationic platelet lysate compositions and related methods
CN116926001A (zh) * 2022-04-06 2023-10-24 上海我武干细胞科技有限公司 血清替代物及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8000527A (nl) * 1980-01-29 1981-08-17 Stichting Vrienden Van De Stic Werkwijze voor het bevorderen van hybridisatie van cellen in vitro en van de produktie en uitscheiding van stoffen, gevormd door dergelijke celhybriden, werkwijze voor het bevorderen van de produktie van monoclonale antilichamen in vitro door toepassing van een hybridomatechniek, alsmede endotheelcellen en/of supernatant van endotheelcellen.
US4350687A (en) * 1980-02-10 1982-09-21 Research Corporation Platelet derived cell growth factor
US4473552A (en) * 1981-03-16 1984-09-25 Jost Leonora I Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells
US4987079A (en) * 1982-07-06 1991-01-22 Wilbur D. Smith Composition and method for in vitro cell culture
US4520107A (en) * 1982-09-28 1985-05-28 Polydex Chemicals Ltd. Tissue culture and cell growth-promoting material and its method of manufacture
US5045468A (en) * 1986-12-12 1991-09-03 Cell Enterprises, Inc. Protein-free culture medium which promotes hybridoma growth
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
US4959308A (en) * 1987-08-27 1990-09-25 Board Of Regents, The University Of Texas System Immunoassay for antibodies binding platelets

Also Published As

Publication number Publication date
EP0413727A1 (de) 1991-02-27
DE68916244T2 (de) 1995-02-09
DE68916244D1 (de) 1994-07-21
US5198357A (en) 1993-03-30
AU3539289A (en) 1989-11-24
SE8801537D0 (sv) 1988-04-26
WO1989010398A1 (en) 1989-11-02
EP0413727B1 (de) 1994-06-15
JPH03505156A (ja) 1991-11-14

Similar Documents

Publication Publication Date Title
ATE107353T1 (de) Blutplättchenlysat, verfahren zu seiner herstellung sowie ein solches lysat enthaltendes zellkulturmedium.
Jaffe et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
Jaffe Culture and identification of large vessel endothelial cells
Craddock et al. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
Samuel et al. Nucleation and growth of fibres and gel formation in sickle cell haemoglobin
Cohn Chemical, physiological, and immunological properties and clinical uses of blood derivatives
GB2025614A (en) Process for preparing a biological composition for use as a reference control in diagnostic analysis
Harris et al. Reticulocyte HL-A Antigens
Kaenhy et al. Relationship between dialyzer reuse and the presence of anti-N-like antibodies in chronic hemodialysis patients
US4374830A (en) Platelet aggregating material from equine arterial tissue
Rosenfeld et al. The accelerating effect of calcium on the fibrinogen-fibrin transformation
Honig et al. Deficiency of Hageman factor (factor XII) in patients with the nephrotic syndrome
Green et al. Phylogeny of immunocompetent cells: III. Mitogen response characteristics of lymphocyte subpopulations from normal and thymectomized frogs (Xenopus laevis)
Gibofsky et al. The identification of HL-A antigens on fresh and cultured human endothelial cells
Parr et al. Primary amyloidosis with plasmacytic dyscrasia and a tetramer of Bence Jones type lambda globulin in the serum and urine
CN109762783A (zh) 一种人脐带华通胶间充质干细胞的制备方法
US4009257A (en) Preparation of immunosuppressive materials
SE8603711L (sv) Metod att framstella humana monoklonala antikroppar
Harris et al. STUDIES ON THE TRANSFER OF LYMPH NODE CELLS: VIII. The Transfer of Cells from Blood and Peritoneal Exudates Incubated in Vitro with Antigenic Material Derived from Shigella Paradysenteriae
JP4110285B2 (ja) 血清の製造方法
Escolar et al. Interaction of long-term stored platelets with vascular subendothelium
CA1245588A (en) Composition for cell cultivation, production and use thereof
Lee et al. A Study of the Effect of Anaphylaxis and Leech extract on the Coagulation of the Blood
Szigeti et al. Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assay
JP4719326B2 (ja) 赤血球の分画法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties